Literature DB >> 21103747

Evaluation of the biological behavior of decellularized pulmonary homografts: an experimental sheep model.

Fábio Binhara Navarro1, Francisco Diniz Affonso da Costa, Leonardo Andrade Mulinari, Gustavo Klug Pimentel, João Gabriel Roderjan, Eduardo Discher Vieira, Lúcia de Noronha, Nelson Itiro Miyague.   

Abstract

INTRODUCTION: The cryopreserved homograft is a good valve substitute due attributes like excellent hemodynamics, low incidence of thromboembolic events, infection resistance and good mid-term durability. However, progressive homograft degeneration and fibrocalcification may occur, particularly in the childhood and young adults. Their antigenicity triggers an immunological reaction that plays an important role in their degeneration and failure. The decellularization process was proposed to decrease this antigenicity. By the action of detergents and enzymes, this process removes all cellular components from the homograft matrix, diminishing immunogenicity and probably delaying its degeneration.
OBJECTIVE: The objective of this experimental and descriptive study is to evaluate the biological and functional behavior of decellularized pulmonary homografts (Decell-H), treated by a sodium dodecil sulfate solution (0.1%), developed in our University (Pontifícia Universidade Católica do Paraná). For the characterization of Decell-H performance, parameters like recellularization, calcification, and echocardiographic data will be analyzed.
METHODS: Eight juvenile sheep were submitted to the implantation of the Decell-H sutured into orthotopic position, through a left thoracotomy and with cardiopulmonary bypass support. They were followed-up clinically and by periodical echocardiograms until the explantation, which were performed in different time for every two sheep: seven, 30, 90 and 180 postoperative days. For histological analysis we used Hematoxilin-eosin, Movat and Alizarin-Red staining.
RESULTS: The sheep reached their follow-up period in a good clinical state. There was no valve regurgitation or stenonis by the echocardiogram. The animals submitted to the explantation in 90 and 180 days had a significant somatic growth and these Decell-H(s) had a diameter increase, without central valve insufficiency. Histologically, all homografts preserved their extra-cellular matrix organization and were progressively recellularized, without calcification.
CONCLUSION: In this experimental model, the Decell-H behaved as an excellent valve substitute.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21103747     DOI: 10.1590/s0102-76382010000300015

Source DB:  PubMed          Journal:  Rev Bras Cir Cardiovasc


  5 in total

1.  Midterm results of homografts in pulmonary position: a retrospective single-center study.

Authors:  Javid Raja; Sabarinath Menon; Sowmya Ramanan; Sudip Dutta Baruah; Arun Gopalakrishnan; Baiju Sasi Dharan
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-11-23

2.  Development and characterization of acellular porcine pulmonary valve scaffolds for tissue engineering.

Authors:  Ji Luo; Sotirios A Korossis; Stacy-Paul Wilshaw; Louise M Jennings; John Fisher; Eileen Ingham
Journal:  Tissue Eng Part A       Date:  2014-06-12       Impact factor: 3.845

Review 3.  A survey of recently published cardiovascular, hematological and pneumological original articles in the Brazilian scientific press.

Authors:  Kavita Kirankumar Patel; Bruno Caramelli; Ariane Gomes
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 4.  Decellularized versus cryopreserved pulmonary allografts for right ventricular outflow tract reconstruction during the Ross procedure: a meta-analysis of short- and long-term outcomes.

Authors:  Adham Ahmed; Sarah Ahmed; Kathryn S Varghese; Dave M Mathew; Roshan Pandey; Dillon O Rogando; Stephanie A Salazar; Peter J Fusco; Kenneth H Levy
Journal:  Egypt Heart J       Date:  2021-11-07

5.  Porcine pulmonary valve decellularization with NaOH-based vs detergent process: preliminary in vitro and in vivo assessments.

Authors:  Mathieu van Steenberghe; Thomas Schubert; Sébastien Gerelli; Caroline Bouzin; Yves Guiot; Daela Xhema; Xavier Bollen; Karim Abdelhamid; Pierre Gianello
Journal:  J Cardiothorac Surg       Date:  2018-04-25       Impact factor: 1.637

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.